Ico Therapeutics Inc (ICO.VN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in thousands)
| 12-2020 | 12-2019 | 12-2018 | 12-2017 | 12-2016 | |
| Cash Flows From Operating Activities | |||||
| Depreciation Amortization | 3 | 3 | 2 | 23 | 27 |
| Accounts receivable | -35 | -284 | -41 | -51 | -13 |
| Other Working Capital | 483 | -302 | 596 | -33 | 9 |
| Other Operating Activity | -1,358 | -1,654 | -1,660 | -1,160 | -1,356 |
| Operating Cash Flow | $-906 | $-2,238 | $-1,104 | $-1,221 | $-1,333 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | 0 | -6 | -3 | 0 | -4 |
| Investing Cash Flow | $0 | $-6 | $-3 | $0 | $-4 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 0 | 2,989 | N/A | N/A | N/A |
| Other Financing Activity | 0 | 228 | 0 | 0 | 0 |
| Financing Cash Flow | $0 | $3,217 | $N/A | $N/A | $N/A |
| Exchange Rate Effect | -18 | 6 | -10 | -12 | -56 |
| Beginning Cash Position | 990 | 10 | 1,128 | 2,361 | 3,754 |
| End Cash Position | 65 | 990 | 10 | 1,128 | 2,361 |
| Net Cash Flow | $-906 | $974 | $-1,108 | $-1,221 | $-1,337 |
| Free Cash Flow | |||||
| Operating Cash Flow | -906 | -2,238 | -1,104 | -1,221 | -1,333 |
| Capital Expenditure | N/A | -6 | -3 | N/A | -4 |
| Free Cash Flow | -906 | -2,244 | -1,108 | -1,221 | -1,337 |